GlassScriptPhysician profile
Kevin Liu
NPI 1831517671
$54,140.54
in general payments reported to CMS, 2019-2025
24 companies · $645 in 2025
The $645 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,524 · 2020: $123 · 2021: $50K · 2022: $477 · 2023: $289 · 2024: $614 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,548.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $52,448.23 | 2019-2025 | Exalt Model D, General - Therapies, Spyglass |
| Abbvie INC. | $376.75 | 2020-2024 | |
| Medtronic, INC. | $255.11 | 2021-2025 | Endoflip |
| Stryker Corporation | $167.08 | 2025 | Pangea |
| Erbe USA INC | $167.00 | 2025 | N/A |
| Cook Medical LLC | $129.40 | 2021-2023 | Echotip |
| Regeneron Healthcare Solutions, INC. | $114.68 | 2023-2024 | Dupixent |
| Genzyme Corporation | $77.83 | 2022-2023 | |
| Pfizer INC. | $47.94 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.67 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.74 | 2022-2023 | Xifaxan |
| Endogastric Solutions, INC | $36.05 | 2022 | |
| Evoke Pharma, INC. | $32.98 | 2024 | |
| Ethicon US, LLC | $26.12 | 2022 | |
| Alcresta Therapeutics, INC. | $23.30 | 2024 | Relizorb |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $22.12 | 2023 | Ibsrela |
| Dynavax Technologies Corporation | $20.37 | 2022 | |
| Redhill Biopharma INC. | $19.42 | 2023 | |
| Ferring Pharmaceuticals INC. | $18.14 | 2022 | |
| Exact Sciences Corporation | $16.78 | 2023 | Cologuard Collection Kit |
| Olympus America INC. | $16.05 | 2025 | Single Use Repositionable Clip |
| Gilead Sciences, INC. | $15.72 | 2023 | |
| W. L. Gore & Associates, INC. | $15.15 | 2022 | |
| Janssen Biotech, INC. | $13.91 | 2023 | Stelara, Simponi Aria, Simponi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.